Clinical trial
Identification of Beneficial and Inhibitory Factors for Treatment in Patients With Anorexia Nervosa: A Pathway to Effective Secondary Prevention and Prognostic Improvement
NCT03713541 is registered in ClinicalTrials.gov with Universitätsklinikum Hamburg-Eppendorf as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identification of Beneficial and Inhibitory Factors for Treatment in Patients With Anorexia Nervosa: A Pathway to Effective Secondary Prevention and Prognostic Improvement
- Lead sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 1, 2018
- Completion date
- April 30, 2022
- Enrollment
- 450 (estimated)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.